-+ 0.00%
-+ 0.00%
-+ 0.00%

BETTA PHARMACEUTICALS <300558.SZ> SAYS U.S. FDA APPROVES CLINICAL TRIAL APPLICATION OF UNIT'S BPI-572270 CAPSULES FOR USE IN TUMORS

Reuters·10/07/2026 09:17:37

Please log in to view news